Trial Profile
A retrospective trial of the effect of adjuvant trastuzumab treatment on survival in patients with metastatic her2+ breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Apr 2014
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Advanced breast cancer; HER2 positive breast cancer
- Focus Therapeutic Use
- 25 Apr 2014 New trial record